Bank of America’s Erasca ERAS Stock Holding History

Bank of America’s Portfolio ERAS Stock Details ERAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,000	Closed	-$16K	–	8268
2022 Q3	$16K	Buy	+2,000	New	+$16.1K	﹤0.01%	7103

Other funds holding ERAS

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Bank of America's ERAS Position: Q1 2026 in Review

Bank of America increased its Erasca (ERAS) stake by 90% in Q1 2026, buying an estimated $17.1M and bringing the position to 3,055,897 shares worth $49.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1604.

Bank of America first reported a position in ERAS in Q3 2021 and has held it in 19 quarters since. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

Bank of America held 3,055,897 shares of Erasca worth $49.4M as of Q1 2026.
Bank of America bought 1,444,047 Erasca shares in Q1 2026, an estimated $17.1M.
Erasca made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1604 holding.
Bank of America first reported a position in Erasca in Q3 2021 and has held it in 19 quarters since.
225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.